Klas Kellerborg

Impact of age at onset on symptom profiles, treatment characteristics and health-related quality of life in Parkinson’s disease

Lars Lau Rakêt, Daniel Oudin Åström, Jenny M. Norlin et al. · Scientific Reports · 2022 · 60 citations · Full text

Cost-Effectiveness of Canagliflozin Added to Standard of Care for Treating Diabetic Kidney Disease (DKD) in Patients with Type 2 Diabetes Mellitus (T2DM) in England: Estimates Using the CREDEM-DKD Model

Michael Willis, Andreas Nilsson, Klas Kellerborg et al. · Diabetes Therapy · 2020 · 33 citations · Full text

Parkinson’s disease in Sweden—resource use and costs by severity

Frida Hjalte, Jenny M. Norlin, Klas Kellerborg et al. · Acta Neurologica Scandinavica · 2021 · 31 citations

High risk of developing dementia in Parkinson’s disease: a Swedish registry-based study

Daniel Oudin Åström, Jacob Simonsen, Lars Lau Rakêt et al. · Scientific Reports · 2022 · 28 citations · Full text

Costs and benefits of early response in the Ebola virus disease outbreak in Sierra Leone

Klas Kellerborg, Werner Brouwer, Pieter van Baal · Cost Effectiveness and Resource Allocation · 2020 · 23 citations · Full text